Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABSORB-2 oral antibiotic absorption study in short bowel syndrome
NL-OMON48315Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2020
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of clindamycin, ciprofloxacin, flucloxacillin and fluconazole in catheter infection (2 cohorts), sponsored by Radboud University Medical Center. Primary endpoint: Relative oral bioavailability. Started Jul 2020; status: active, not recruiting.
02
Drugs
clindamycinciprofloxacinflucloxacillinfluconazole
03
Conditions
catheter infection
Beyond the preview
Go deeper on NL-OMON48315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48315.